IDH1 mutations occur less frequently than IDH2 in total AML population (7.7% for IDH1 vs 15.4% for IDH2) and lead to a substitution of arginine 132 for either histidine or cysteine (R132H and R132C)4. Here, IDH1 is linked to acute myeloid leukemia.